Page last updated: 2024-10-25

clonidine and Alport Syndrome

clonidine has been researched along with Alport Syndrome in 1 studies

Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.

Research Excerpts

ExcerptRelevanceReference
" Even when drug-resistance appears to be responsible for the failure to control secondary hypertension in AS, clonidine may represent a safe, effective option in the normalization of high blood pressure."3.76Ventricular septal defect in a child with Alport syndrome: a case report. ( Bassareo, PP; Marras, AR; Mercuro, G, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bassareo, PP1
Marras, AR1
Mercuro, G1

Other Studies

1 other study available for clonidine and Alport Syndrome

ArticleYear
Ventricular septal defect in a child with Alport syndrome: a case report.
    BMC cardiovascular disorders, 2010, Oct-05, Volume: 10

    Topics: Adrenergic alpha-2 Receptor Agonists; Antihypertensive Agents; Clonidine; Collagen Type IV; Disease

2010